377 related articles for article (PubMed ID: 28127506)
21. [Nursing care of chemotherapy-induced peripheral neuropathy].
Hsu SY; Lu CH; Chen SZ; Jane SW
Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
[TBL] [Abstract][Full Text] [Related]
22. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
23. Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening.
Rana P; Luerman G; Hess D; Rubitski E; Adkins K; Somps C
Toxicol In Vitro; 2017 Dec; 45(Pt 1):111-118. PubMed ID: 28843493
[TBL] [Abstract][Full Text] [Related]
24. Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study.
Ward PR; Wong MD; Moore R; Naeim A
J Geriatr Oncol; 2014 Jan; 5(1):57-64. PubMed ID: 24484719
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models.
Carozzi VA; Chiorazzi A; Canta A; Meregalli C; Oggioni N; Cavaletti G; Marmiroli P
Exp Neurol; 2015 Feb; 264():92-102. PubMed ID: 25450467
[TBL] [Abstract][Full Text] [Related]
26. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy-induced neuropathy].
Boehmerle W; Huehnchen P; Endres M
Nervenarzt; 2015 Feb; 86(2):156-60. PubMed ID: 25586233
[TBL] [Abstract][Full Text] [Related]
28. Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy-induced peripheral neuropathy.
White D; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G; Lees JG
J Peripher Nerv Syst; 2023 Jun; 28(2):179-190. PubMed ID: 36995049
[TBL] [Abstract][Full Text] [Related]
29. Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.
Kassem LA; Yassin NA
Pak J Biol Sci; 2010 Jun; 13(12):577-87. PubMed ID: 21061908
[TBL] [Abstract][Full Text] [Related]
30. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
31. Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
Argyriou AA; Zolota V; Kyriakopoulou O; Kalofonos HP
J BUON; 2010; 15(3):435-46. PubMed ID: 20941808
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
33. Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy.
Müller J; Ringhof S; Vollmer M; Jäger LB; Stein T; Weiler M; Wiskemann J
Gait Posture; 2020 Mar; 77():156-163. PubMed ID: 32036320
[TBL] [Abstract][Full Text] [Related]
34. Patient perceptions associated with chemotherapy-induced peripheral neuropathy.
Tofthagen C
Clin J Oncol Nurs; 2010 Jun; 14(3):E22-8. PubMed ID: 20529785
[TBL] [Abstract][Full Text] [Related]
35. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
Gießen-Jung C; von Baumgarten L
Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
[TBL] [Abstract][Full Text] [Related]
37. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
38. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced peripheral neuropathies.
Argov Z; Mastaglia FL
Br Med J; 1979 Mar; 1(6164):663-6. PubMed ID: 219931
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathy in hematologic malignancies - Past, present and future.
Li T; Timmins HC; Lazarus HM; Park SB
Blood Rev; 2020 Sep; 43():100653. PubMed ID: 31983507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
